ReShape Lifesciences Inc. (RSLS)

Aug 15, 2025 - RSLS was delisted (reason: merged into HIND)

15.68

0.00 (0.00%)

Inactive · Last trade price on Aug 14, 2025

ReShape Lifesciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	6.45	8.01	8.68	11.24	13.6	11.3
Revenue Growth	-19.81%	-7.74%	-22.79%	-17.35%	20.36%	-25.12%
Gross Profit	4.04	5.06	5.55	6.8	8.35	6.26
Operating Income	-6.66	-6.67	-14.64	-27.08	-24.96	-12.46
Net Income	-4.5	-7.13	-11.39	-46.21	-63.15	-21.63
Earnings Per Share	-55.33	-345.73	-	-	-	-
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	7.13	9.23	10.3	1.11	2.39
Europe	0.96	1.25	2.13	-	-
Australia	0.53	0.69	1.04	-	-
Rest of World	0.06	0.07	0.14	0.48	0.89

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	4.12	0.69	4.46	3.86	22.77	2.96
Total Debt	0.1	0.97	0.26	0.17	0.28	13.25
Net Cash (Debt)	4.02	-0.27	4.2	3.68	22.49	-10.3
Net Cash Growth	380.17%	-	13.93%	-83.62%	-	-
Net Cash Per Share	49.41	-13.29	-	-	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-7.61	-4.43	-16.96	-21.9	-15.38	-8.55
Capital Expenditures	-	-	-0.04	-0.13	-0.35	-0.39
Free Cash Flow	-7.61	-4.43	-17	-22.03	-15.73	-8.94
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	62.59%	63.17%	63.93%	60.52%	61.38%	55.42%
Operating Margin	-103.18%	-83.29%	-168.69%	-240.91%	-183.50%	-110.25%
Pretax Margin	-69.33%	-88.57%	-130.62%	-414.54%	-466.32%	-193.03%
Profit Margin	-69.72%	-89.06%	-131.22%	-411.16%	-464.31%	-191.43%
FCF Margin	-117.96%	-55.30%	-195.93%	-196.02%	-115.64%	-79.12%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '26 Jul 28, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PS Ratio	0.20	0.40	0.53	0.29	2.13	1.73